Dr. Asta Försti

Dr. Asta Försti

Dr. Asta Försti

Position:

Senior Scientist

Phone:

+49.62 21.42-18 03

Fax:

+49.62 21.42-18 10

Building:

TP 3

Room:

B3.203

Education

1984 M.Sc. in Biochemistry, University of Kuopio, Finland
1992 PhD in Biochemistry and Biotechnology, University of Kuopio, Finland

Research field

breast cancer, colorectal cancer, genom-wide association studies, SNP array, DNA sequencing

Selected publications

Hemminki K, Musak L, Vymetalkova V, Smerhovsky Z, Halasova E, Osina O, Letkova L, Försti A, Vodickova L, Buchancova J, Vodicka P. Cyclin D1 splice site variant triggers chromosomal aberrations in healthy humans. Leukemia. 2014;28:721-2.

Figlioli G, Chen B, Elisei R, Romei C, Campo C, Cipollini M, Cristaudo A, Bambi F, Paolicchi E, Hoffmann P, Herms S, Kalemba M, Kula D, Pastor S, Marcos R, Velázquez A, Jarząb B, Landi S, Hemminki K, Gemignani F, Försti A. Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk. Sci Rep 2015;5:8922.

Weinhold N, Meissner T, Johnson DC, Seckinger A, Moreaux J, Försti A, Chen B, Nickel J, Chubb D, Rawstron AC, Doughty C, Dahir NB, Begum DB, Young K, Walker BA, Hoffmann P, Nöthen MM, Davies FE, Klein B, Goldschmidt H, Morgan GJ, Houlston R, Hose D, Hemminki K. The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells. Haematologica 2015;100(3):e110-3.

Thomsen H, da Silva Filho MI, Försti A, Fuchs M, Ponader S, von Strandmann EP, Eisele L, Herms S, Hofmann P, Sundquist J, Engert A, Hemminki K. Heritability estimates on Hodgkin's lymphoma: a genomic-versus population-based approach. Eur J Hum Genet 2015;(6):824-30.

Chen T, Fallah M, Försti A, Kharazmi E, Sundquist K, Hemminki K. Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas. JAMA Dermatol 2015;151(6):607-15.

to top